Literature DB >> 19105184

Chromosomal and proteome analysis of a new T24-based cell line model for aggressive bladder cancer.

Manousos Makridakis1, Sarantis Gagos, Andreas Petrolekas, Maria G Roubelakis, Vasiliki Bitsika, Konstantinos Stravodimos, Kitty Pavlakis, Nicholas P Anagnou, Jonathan Coleman, Antonia Vlahou.   

Abstract

Cell line models aid in understanding cancer aggressiveness. The aim of this study was the establishment of a metastatic variant (T24M) of the T24 bladder cancer cell line and its initial characterization at chromosomal and proteomic levels. T24M were spontaneously developed in mice from T24 cells, following cycles of subcutaneous injections and culture in vitro. Transwell migration assays and injections in mice revealed increased migration and tumorigenic properties of T24M compared to the T24 cells. Cytogenetic analysis demonstrated that T24M retained several karyotypic characteristics of the parental cells and also acquired novel chromosomal aberrations related to aggressive bladder cancer. Proteomic analysis of the T24 and T24M cells by 2-DE and MS led to the generation of their 2-DE proteomic map and revealed differences in multiple proteins. These include proteases of the lysosomal and proteasome degradation pathways, mitochondrial and cytoskeletal proteins. The 2-DE findings were confirmed by immunoblotting of cell lysates and immunohistochemistry of bladder cancer tissue sections for cathepsin D and activity assays for proteasome. Collectively, our results suggest that the T24M cells reflect many known chromosomal and proteomic aberrations encountered in aggressive bladder cancers but also provide access to novel findings with potentially clinical applications.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19105184     DOI: 10.1002/pmic.200800121

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  14 in total

1.  Platelet-rich plasma (PRP) promotes fetal mesenchymal stem/stromal cell migration and wound healing process.

Authors:  Maria G Roubelakis; Ourania Trohatou; Apostolos Roubelakis; Evgenia Mili; Ioannis Kalaitzopoulos; Georgios Papazoglou; Kalliopi I Pappa; Nicholas P Anagnou
Journal:  Stem Cell Rev Rep       Date:  2014-06       Impact factor: 5.739

2.  Genomic characterization of three urinary bladder cancer cell lines: understanding genomic types of urinary bladder cancer.

Authors:  Rosário Pinto-Leite; Isabel Carreira; Joana Melo; Susana Isabel Ferreira; Ilda Ribeiro; Jaqueline Ferreira; Marco Filipe; Carina Bernardo; Regina Arantes-Rodrigues; Paula Oliveira; Lúcio Santos
Journal:  Tumour Biol       Date:  2014-01-24

3.  Alternative lengthening of telomeres: recurrent cytogenetic aberrations and chromosome stability under extreme telomere dysfunction.

Authors:  Despoina Sakellariou; Maria Chiourea; Christina Raftopoulou; Sarantis Gagos
Journal:  Neoplasia       Date:  2013-11       Impact factor: 5.715

Review 4.  High Resolution Proteomic Analysis of the Cervical Cancer Cell Lines Secretome Documents Deregulation of Multiple Proteases.

Authors:  Kalliopi I Pappa; Georgia Kontostathi; Manousos Makridakis; Vasiliki Lygirou; Jerome Zoidakis; George Daskalakis; Nicholas P Anagnou
Journal:  Cancer Genomics Proteomics       Date:  2017 Nov-Dec       Impact factor: 4.069

5.  Profilin 1 is a potential biomarker for bladder cancer aggressiveness.

Authors:  Jerome Zoidakis; Manousos Makridakis; Panagiotis G Zerefos; Vasiliki Bitsika; Sergio Esteban; Maria Frantzi; Konstantinos Stravodimos; Nikolaos P Anagnou; Maria G Roubelakis; Marta Sanchez-Carbayo; Antonia Vlahou
Journal:  Mol Cell Proteomics       Date:  2011-12-08       Impact factor: 5.911

6.  Proteomic Analysis of Normal and Cancer Cervical Cell Lines Reveals Deregulation of Cytoskeleton-associated Proteins.

Authors:  Kalliopi I Pappa; Vasiliki Lygirou; Georgia Kontostathi; Jerome Zoidakis; Manousos Makridakis; Konstantinos Vougas; George Daskalakis; Alexander Polyzos; Nicholas P Anagnou
Journal:  Cancer Genomics Proteomics       Date:  2017 Jul-Aug       Impact factor: 4.069

7.  New cathepsin D inhibitor library utilizing hydroxyethyl isosteres with cyclic tertiary amines.

Authors:  Rose M McConnell; Kalyani Inapudi; Naveen Kadasala; Karthika Yarlagadda; Priya Velusamy; Matthew S McConnell; Adam Green; Carol Trana; Kelley Sayyar; James S McConnell
Journal:  Med Chem       Date:  2012-11       Impact factor: 2.745

8.  Visualizing meta-features in proteomic maps.

Authors:  Eugenia G Giannopoulou; George Lepouras; Elias S Manolakos
Journal:  BMC Bioinformatics       Date:  2011-07-28       Impact factor: 3.169

9.  Integrative analysis of extracellular and intracellular bladder cancer cell line proteome with transcriptome: improving coverage and validity of -omics findings.

Authors:  Agnieszka Latosinska; Manousos Makridakis; Maria Frantzi; Daniel M Borràs; Bart Janssen; William Mullen; Jerome Zoidakis; Axel S Merseburger; Vera Jankowski; Harald Mischak; Antonia Vlahou
Journal:  Sci Rep       Date:  2016-05-11       Impact factor: 4.379

10.  Proteomics analysis of bladder cancer invasion: Targeting EIF3D for therapeutic intervention.

Authors:  Agnieszka Latosinska; Marika Mokou; Manousos Makridakis; William Mullen; Jerome Zoidakis; Vasiliki Lygirou; Maria Frantzi; Ioannis Katafigiotis; Konstantinos Stravodimos; Marie C Hupe; Maciej Dobrzynski; Walter Kolch; Axel S Merseburger; Harald Mischak; Maria G Roubelakis; Antonia Vlahou
Journal:  Oncotarget       Date:  2017-04-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.